What's new on the horizon for polycystic ovarian syndrome? Exploring emerging drugs in phase II

Expert Opin Emerg Drugs. 2023 Dec;28(3):149-152. doi: 10.1080/14728214.2023.2260746. Epub 2023 Oct 12.

Authors

Giuseppe D'Angelo¹, Mario Ascione¹, Ilaria Morra¹, Paolo Verrazzo², Giuseppe Bifulco¹, Pierluigi Giampaolino¹, Luigi Della Corte³

Affiliations

¹ Department of Public Health, University of Naples Federico II, Naples, Italy.
² Hospital Santa Maria delle Grazie of Pozzuoli - ASL Napoli 2 Nord, Naples, Italy.
³ Department of Neuroscience, Reproductive Sciences and Dentistry, School of Medicine, University of Naples Federico II, Naples, Italy.

PMID: 37725478
DOI: 10.1080/14728214.2023.2260746

No abstract available

Keywords: GnRH Antagonists; Neurokinin B Receptor Antagonism; PCOS; SGLT1/2; emerging drugs.

Publication types

Editorial

MeSH terms

Female
Humans
Polycystic Ovary Syndrome* / drug therapy